Skip to main content
. 2023 Feb 10;25:19. doi: 10.1186/s13058-022-01598-w

Table1.

Clinicopathologic parameters of 13 HR+HER2− breast cancer patients

Variables n (%)
Age (years)
 Median 52.00
Clinical T stage
 cT1-2 6 (46.2)
 cT3-4 7 (53.8)
NAC regimen
 AC-T/P 11 (84.6)
 TAC 2 (15.4)
NAC cycles
 ≤ 4 9 (69.2)
 > 4 4 (30.8)
Residual tumour size
 ≤ 2 cm 1 (7.7)
 > 2 cm 12 (92.3)
Nodal status
 Neg 5 (38.5)
 Pos 8 (61.5)

NAC neoadjuvant chemotherapy